NSCLC tissues; paired adjacent normal tissues
A549; SPC-A1; NCI-H1703; NCI-H1299; H1975; 16-HBE
-
glycolysis (promotes); proliferation (promotes); invasion (promotes); migration (promotes)
RNA-seq; RT-qPCR; RNase R Treatment; divergent primers PCR; Sanger Sequencing; Nuclear-Cytoplasmic Fractionation; RNA Pull-Down; Transfection; CCK8; Transwell Assay; Wound Healing Assay; Bioinformatics Analysis; Clinical Sample Validation; Survival Analysis
High circRARS expression is associated with smoking status, lymph node metastasis, higher tumor stage, and poor overall survival; may be a prognostic biomarker in NSCLC.
circRARS (hsa_circ_0001551), derived from RARS, is up-regulated in NSCLC/LUAD and associates with aggressive clinicopathologic features and poorer overall survival. Functionally, circRARS promotes proliferation, invasion, migration, and aerobic glycolysis, at least partly by binding LDHA and enhancing LDHA activity while upregulating LDHA expression at the transcriptional level.
0.8369
Circular RNA, circular RARS, promotes aerobic glycolysis of non-small-cell lung cancer by binding with LDHA.
combined biological and clinical study